{"id":309600,"date":"2019-12-12T19:16:06","date_gmt":"2019-12-13T03:16:06","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/cstone-completes-registration-filing-for-the-phase-i-trial-cs3005\/"},"modified":"2019-12-12T19:16:38","modified_gmt":"2019-12-13T03:16:38","slug":"%e6%96%b0%e9%80%b2%e5%b1%95%e5%9f%ba%e7%9f%b3%e8%97%a5%e6%a5%ad%e8%85%ab%e7%98%a4%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95-cs3005-%e5%82%b3%e5%96%9c%e8%a8%8a","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/12\/%e6%96%b0%e9%80%b2%e5%b1%95%e5%9f%ba%e7%9f%b3%e8%97%a5%e6%a5%ad%e8%85%ab%e7%98%a4%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95-cs3005-%e5%82%b3%e5%96%9c%e8%a8%8a\/","title":{"rendered":"\u65b0\u9032\u5c55\uff01\u57fa\u77f3\u85e5\u696d\u816b\u7624\u514d\u75ab\u7642\u6cd5CS3005\u50b3\u559c\u8a0a"},"content":{"rendered":"<p>\u57fa\u77f3\u85e5\u696d\u4eca\u5929\u5ba3\u4f48\uff0c\u8a72\u516c\u53f8CS3005 \u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u6700\u8fd1\u7372\u5f97\u4e86\u6fb3\u5927\u5229\u4e9e\u4eba\u985e\u7814\u7a76\u502b\u7406\u59d4\u54e1\u6703\uff08HREC\uff09\u7684\u6279\u51c6\uff0c\u4e26\u7372\u5f97\u4e86\u6fb3\u5927\u5229\u4e9e\u6cbb\u7642\u7522\u54c1\u7ba1\u7406\u5c40\uff08TGA\uff09\u7684\u8a8d\u53ef\u3002 CS3005\u662f\u4e00\u9805\u958b\u653e\u6027\u3001\u591a\u4e2d\u5fc3\u3001\u5291\u91cf\u905e\u589e\u7684I\u671f\u7814\u7a76\uff0c\u65e8\u5728\u8a55\u4f30CS3005\u5728\u665a\u671f\u5be6\u9ad4\u7624\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\u53ca\u521d\u6b65\u6297\u816b\u7624\u6d3b\u6027\u3002<\/p>\n<p>\u816b\u7624\u5fae\u74b0\u5883\uff08TME\uff09\u662f\u6307\u816b\u7624\u7d30\u80de\u6240\u8655\u7684\u5167\u5916\u74b0\u5883\uff0c\u816b\u7624\u5728\u5176\u4e2d\u8207\u5468\u570d\u7684\u8840\u7ba1\u3001\u514d\u75ab\u7d30\u80de\u3001\u57fa\u8cea\u6210\u5206\u767c\u751f\u52d5\u614b\u7684\u76f8\u4e92\u4f5c\u7528\u3002\u7814\u7a76\u986f\u793a\uff0c\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u5b58\u5728\u7684\u591a\u7a2e\u4ee3\u511f\u6027\u514d\u75ab\u6291\u5236\u6a5f\u5236\u4e0d\u50c5\u8207\u816b\u7624\u7684\u767c\u751f\u6709\u95dc\uff0c\u9084\u5c07\u5f71\u97ff\u5c0d\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u7684\u97ff\u61c9\u7387\u3002\u5176\u4e2d\uff0c\u817a\u82f7\u4fe1\u865f\u901a\u8def\u5c31\u5728\u6a5f\u9ad4\u5167\u767c\u63ee\u91cd\u8981\u7684\u514d\u75ab\u8abf\u7bc0\u4f5c\u7528\uff0c\u662f\u5c0d\u65bc\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u7684\u4e00\u7a2e\u91cd\u8981\u4ee3\u511f\u6027\u62b5\u6297\u6a5f\u5236\u3002<\/p>\n<p>CS3005\u662f\u7531\u57fa\u77f3\u85e5\u696d\u767c\u73fe\u7684\u4e00\u7a2e\u817a\u82f7A2a\u53d7\u9ad4\u62ee\u6297\u5291\uff0c\u53ef\u8abf\u7bc0\u816b\u7624\u514d\u75ab\u5fae\u74b0\u5883\u3002 CS3005\u53ef\u80fd\u901a\u904e\u963b\u65b7\u817a\u82f7\u8207\u817a\u82f7A2a\u53d7\u9ad4\u7684\u7d50\u5408\u5f9e\u800c\u9006\u8f49\u514d\u75ab\u6291\u5236\u6a5f\u5236\uff0c\u5f9e\u800c\u6f5b\u5728\u5730\u6fc0\u6d3b\u6297\u816b\u7624\u514d\u75ab\u529b\u4e26\u6539\u5584\u5c0d\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u7684\u53cd\u61c9\u3002\u76ee\u524d\uff0c\u5168\u7403\u5c1a\u7121\u6279\u51c6\u817a\u82f7A2a\u53d7\u9ad4\u62ee\u6297\u5291\u7528\u65bc\u764c\u75c7\u6cbb\u7642\u3002<\/p>\n<p>\u57fa\u77f3\u85e5\u696d\u8463\u4e8b\u9577\u517c\u9996\u5e2d\u57f7\u884c\u5b98\u6c5f\u752f\u8ecd\u535a\u58eb\u8868\u793a\uff1a\u201c\u5f88\u9ad8\u8208\u770b\u5230CS3005\u7684\u81e8\u5e8a\u8a66\u9a57\u5728\u6fb3\u6d32\u7372\u6279\uff0cCS3005\u662f\u516c\u53f8\u7b2c\u4e00\u6b3e\u5373\u5c07\u9032\u5165\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\u7684\u816b\u7624\u514d\u75ab\u5fae\u74b0\u5883\u8abf\u7bc0\u5291\u3002\u8fd1\u5e74\u4f86\uff0c\u514d\u75ab\u7642\u6cd5\u7d66\u665a\u671f\u764c\u75c7\u75c5\u4eba\u5e36\u4f86\u4e86\u66d9\u5149\uff0c\u907a\u61be\u7684\u662f\u76ee\u524d\u4ecd\u6709\u773e\u591a\u60a3\u8005\u7121\u6cd5\u5c0d\u5176\u7522\u751f\u61c9\u7b54\u3002\u6211\u5011\u671f\u5f85\u901a\u904e\u5c0d\u816b\u7624\u5fae\u74b0\u5883\u8abf\u7bc0\u5291\u7684\u63a2\u7d22\u8207\u958b\u767c\uff0c\u80fd\u5920\u64f4\u5927\u514d\u75ab\u6cbb\u7642\u7684\u7372\u76ca\u4eba\u7fa4\u3002\u201d<\/p>\n<p>\u57fa\u77f3\u85e5\u696d\u7684\u9996\u5e2d\u79d1\u5b78\u5b98\u738b\u8f9b\u4e2d\u535a\u58eb\u6307\u51fa\uff1a\u201c\u65e9\u671f\u5c0d\u817a\u82f7A2a\u53d7\u9ad4\u62ee\u6297\u5291\u7684\u7814\u7a76\u986f\u793a\uff0c\u5c0d\u65bc\u665a\u671f\u5be6\u9ad4\u7624\u60a3\u8005\uff0c\u7121\u8ad6\u662f\u55ae\u4e00\u7642\u6cd5\u9084\u662f\u8207\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u806f\u5408\u4f7f\u7528\uff0c\u90fd\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u6297\u816b\u7624\u6d3b\u6027\u3002\u5373\u4f7f\u662f\u5728PD-L1\u4f4e\u8868\u9054\uff0c\u6216\u8005\u5c0dPD-(L)1\u6291\u5236\u5291\u8010\u85e5\u6216\u62b5\u6297\u7684\u60a3\u8005\u4e2d\uff0c\u817a\u82f7A2a\u53d7\u9ad4\u62ee\u6297\u5291\u4e5f\u5177\u6709\u7642\u6548\uff0c\u9019\u9810\u793a\u8457\u5b83\u5c07\u6709\u53ef\u80fd\u8b93\u591a\u7a2e\u5be6\u9ad4\u7624\u60a3\u8005\u7372\u76ca\u3002\u540c\u6642CS3005\u4e5f\u9032\u4e00\u6b65\u62d3\u5c55\u4e86\u57fa\u77f3\u85e5\u696d\u5728\u514d\u75ab\u7d44\u5408\u6cbb\u7642\u7b56\u7565\u7684\u6df1\u5ea6\u548c\u9748\u6d3b\u6027\u3002\u201d<\/p>\n<p>\u57fa\u77f3\u85e5\u696d\uff08HKEX\uff1a2616\uff09\u662f\u4e00\u5bb6\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u548c\u5546\u696d\u5316\u5275\u65b0\u7684\u514d\u75ab\u816b\u7624\u5b78\u548c\u7cbe\u5bc6\u85e5\u7269\uff0c\u4ee5\u6eff\u8db3\u4e2d\u570b\u548c\u5168\u7403\u764c\u75c7\u60a3\u8005\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002 \u57fa\u77f3\u85e5\u696d\u6210\u7acb\u65bc2015\u5e74\uff0c\u5df2\u7d93\u7d44\u5efa\u4e86\u4e00\u652f\u4e00\u6d41\u7684\u7ba1\u7406\u5718\u968a\uff0c\u5728\u5275\u65b0\u85e5\u7269\u958b\u767c\u3001\u81e8\u5e8a\u7814\u7a76\u548c\u5546\u696d\u5316\u65b9\u9762\u64c1\u6709\u8c50\u5bcc\u7684\u7d93\u9a57\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CStone Pharmaceuticals (&#8220;CStone&#8221; or the &#8220;Company&#8221;, HKEX: 2616) today announced that the Company has recently received the approval from the Human Research Ethics Committee (HREC) in Australia, and the acknowledgement from Australia&#8217;s Therapeutic Goods Administration (TGA) on the Phase I clinical trial of CS3005.<\/p>\n","protected":false},"author":9,"featured_media":309576,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[809,927,563,644,564],"class_list":["post-309600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-809","tag-927","tag--zh-hant","tag-644","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/309600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=309600"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/309600\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/309576"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=309600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=309600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=309600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}